Pilot Study of tSCS for Improving Upper Limb Function in People With Multiple Sclerosis

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Multiple Sclerosis
Interventions
DEVICE

Active stimulation tSCS

Active transcutaneous spinal cord stimulation (tSCS) delivered with the SCONE™ device. Electrical currents are applied non-invasively through surface electrodes placed on the skin over the spine. Sessions are combined with standardized upper limb rehabilitation therapy. Participants receive stimulation twice per week for 12 weeks.

DEVICE

Sham: stimulations using a non-active electric stimulation

Sham stimulation delivered with the SCONE™ device, using identical setup and procedures as the active intervention but without effective current. This procedure is designed to mimic the sensation and experience of active stimulation while delivering no therapeutic neuromodulation. Participants also perform standardized upper limb rehabilitation therapy twice per week for 12 weeks.Transcutaneous Spinal Cord Stimulation (tSCS) - Sham (SCONE™)

BEHAVIORAL

Occupational/Upper Limb Rehabilitation Therapy

Standardized occupational therapy program focused on upper limb function. Sessions are delivered in combination with either active or sham transcutaneous spinal cord stimulation.

Trial Locations (1)

08003

Hospital del Mar, Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT07152145 - Pilot Study of tSCS for Improving Upper Limb Function in People With Multiple Sclerosis | Biotech Hunter | Biotech Hunter